Ij. Martins et al., EFFECT OF THE ACAT INHIBITOR CL-277,082 ON APOLIPOPROTEIN B48 TRANSPORT IN MESENTERIC LYMPH AND ON PLASMA-CLEARANCE OF CHYLOMICRONS AND REMNANTS, Arteriosclerosis, thrombosis, and vascular biology, 17(1), 1997, pp. 211-216
Inhibitors of acyl CoA:cholesterol acyltransferase (ACAT) activity pre
viously have been found to decrease the absorption of cholesterol and
to be effective antiatherosclerotic agents. Effects on chylomicron (CM
) transport could contribute to these effects. No previous study has e
xamined the effect of inhibition of ACAT activity on the intestinal ly
mph output of apolipoprotein (apo) B48 or on the clearance from plasma
of lymph CM. In this study, we selected (2,2-dimethylpropyl)phenyl]me
thyl]-N-(hepthyl)urea (CL 277,082) to inhibit intestinal ACAT activity
and measured its effects on the output of lipids and apo B48 in intes
tinal lymph. Compared with control untreated rats, treatment with CL 2
77,082 decreased the lymph outputs of apo B48 and triglyceride. Associ
ated with the effects on transport, the lymph CM were smaller in diame
ter in rats treated with CL 277,082. The unesterified cholesterol cont
ent of lymph CM was markedly increased and the cholesteryl ester (CE)
content was decreased. The contents of triglyceride were decreased and
phospholipid was increased. Labeled CM were prepared by feeding donor
rats with a test meal containing H-3-cholesterol and C-14-fatty acid.
Traced by the CE label in lymph CM in both control rats and rats trea
ted with CL 277,082, the remnants derived after intravenous injection
of CM from rats treated with CL 277,082 were cleared significantly mor
e slowly than CM from untreated rats. Moreover, less CE label was reco
vered in the livers of both groups of rats after injection of CM from
rats treated with CL 277,082. Recovery in the spleen was significantly
higher in recipient rats injected with CM from rats treated with CL 2
77,082 when compared with injections of CM obtained from untreated rat
s. We conclude that the metabolism of CM is affected by treatment with
CL 277,082, partly due to the changes in lymph CM composition and par
tly due to other effects on the recipient rat.